search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
INF ECTION P R EVENTION


Biological Indicators (BIs), which are considered to be the industry standard tool for determining hydrogen peroxide vapour decontamination efficacy. Full documentation was provided via a final report outlining all areas decontaminated including locations of biological indicators with incubation results displaying validated efficacy. Not only available as a service response, Bioquell systems are deployed around the world for everyday use in hospitals and care providers in the fight against the pandemic. A specialist unit at a Singapore hospital has selected multiple Bioquell units to help them in their response to control the spread of infections. As a current client of Bioquell, they expanded their capacity to decontaminate rooms, allowing them to support the running of a higher number of decontamination cycles following terminal clean as their current workload increased 300% on last year. Hospitals in the United States, Scandinavia, China, Qatar, New Zealand, and more, have all invested in Bioquell decontamination equipment to help eliminate organisms on every exposed surface in between patient admission. In fact, just prior to the pandemic, one of


Britain’s busiest hospitals, St Thomas’ hospital, which takes in patients from all over the world, worked with Bioquell on a nine-month trial assessing the impact of Bioquell’s hydrogen peroxide vapour decontamination system. As for any hospital, maintaining a low rate of hospital acquired infections is a top priority. That is why this facility required a room decontamination solution that could provide a 6-log sporicidal kill within hospital rooms performed as rapidly as possible in the short window that a hospital bed space is unoccupied. St Thomas’ needed the ability to decontaminate larger, open patient areas to help minimise the spread of infection between patients.


During the nine-month trial, Bioquell


performed over 460 room decontaminations, and, at one point, the system was used non- stop over a 72-hour period to help combat an outbreak on the ICU. By providing 6-log decontamination cycles in patient rooms and larger critical areas like operating theatres, the Bioquell system played a key role in minimising the spread of healthcare-acquired infections within the hospital. Ultimately, SARS-CoV-2 is estimated to


survive several days on skin and on surfaces, according to several scientific studies5,6


.


Frequent cleaning and disinfection of surfaces and proper hand hygiene have been identified as critical measures to help stop the spread of SARS-CoV-2, according to the World Health Organization.7


Effective hand


hygiene and surface disinfection are critical in preventing the spread of viral infection and are central pillars in protecting patients and staff as UK hospitals continue to face challenges in tackling the coronavirus. CSJ


References 1 Erasmus et al. Systematic review of studies on compliance with hand hygiene guidelines in hospital care, Infect Control Hosp Epidemiol 2010; 31:283- 94.


2 WHO Guidelines on Hand Hygiene in Healthcare, 2009


3 Stewardson A, Pittet D. Anatomy of a successful multimodal hand hygiene campaign. BMJ Qual Saf. 2012 Dec;21(12):973-5. doi: 10.1136/ bmjqs-2012-001452. Epub 2012 Oct 13. PMID: 23064764.


4 Ecolab Hand Hygiene Program Case Study; Provincial Polyclinic Hospital in Torun, Poland. Available upon request.


5 Aerosol and surface stability of HCoV-19 (SARS-


CoV-2) compared to SARS-CoV-1. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. N Engl J Med. 2020 Mar 17. doi: 10.1056/ NEJMc2004973.. PMID: 32182409.


6 Ryohei Hirose, Hiroshi Ikegaya, Yuji Naito, Naoto Watanabe, Takuma Yoshida, Risa Bandou, Tomo Daidoji, Yoshito Itoh, Takaaki Nakaya, Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19, Clinical Infectious Diseases, ciaa1517, https://doi. org/10.1093/cid/ciaa1517


7 https://www.who.int/infection-prevention/ campaigns/clean-hands/WHO_HH-Community- Campaign_finalv3.pdf


Ellie Wishart


Ellie Wishart, BSc (Hons), is the real world evidence manager Europe, at Ecolab. She is responsible for real world evidence (RWE) and scientific affairs for Ecolab’s Healthcare Division in Europe and has been involved in the provision of infection prevention solutions to healthcare facilities for over 15 years with Ecolab.


Ellie is responsible for building scientific data, RWE and clinical practices that support Ecolab’s programmes and works to empower education, practical knowledge and best practices in infection prevention.


48 l WWW.CLINICALSERVICESJOURNAL.COM


George Olden


George Olden is the EMEA healthcare manager at Bioquell. After seven years working across various roles in Bioquell’s healthcare team, George is responsible for commercial operations across Europe, the Middle East and Africa. Working closely with infection prevention and control teams around the world, often via Bioquell’s network of highly skilled distributors, George and the wider Bioquell team are passionate about providing enhanced decontamination solutions, backed by extensive research, with the ultimate goal of helping healthcare providers in tackling HCAIs.


JANUARY 2021


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80